Current Status of HIV-1 Vaccines
HIV-1 infection and its progression to AIDS remains a significant global health challenge, particularly for low-income countries. Developing a vaccine to prevent HIV-1 infections has proven to be immensely challenging with complex biological acquisition and infection, unforeseen clinical trial disap...
Main Authors: | Anna Hargrave, Abu Salim Mustafa, Asma Hanif, Javed H. Tunio, Shumaila Nida M. Hanif |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/9/1026 |
Similar Items
-
Recent Advances in Cancer Immunotherapy with a Focus on FDA-Approved Vaccines and Neoantigen-Based Vaccines
by: Anna Hargrave, et al.
Published: (2023-10-01) -
Immune Responses to Methicillin-Resistant <i>Staphylococcus aureus</i> Infections and Advances in the Development of Vaccines and Immunotherapies
by: John Scully, et al.
Published: (2024-09-01) -
Recent Updates on mRNA Vaccines
by: Emily Sydow, et al.
Published: (2022-07-01) -
Conserved multiepitope vaccine constructs: A potent HIV-1 therapeutic vaccine in clinical trials
by: Elahe Akbari, et al.
Published: (2023-05-01) -
What Has 30 Years of HIV Vaccine Research Taught Us?
by: José Esparza
Published: (2013-10-01)